GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raily Aesthetic Medicine International Holdings Ltd (HKSE:02135) » Definitions » Enterprise Value

Raily Aesthetic Medicine International Holdings (HKSE:02135) Enterprise Value : HK$93.4 Mil (As of Jun. 08, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Raily Aesthetic Medicine International Holdings Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Raily Aesthetic Medicine International Holdings's Enterprise Value is HK$93.4 Mil. Raily Aesthetic Medicine International Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-35.2 Mil. Therefore, Raily Aesthetic Medicine International Holdings's EV-to-EBIT ratio for today is -2.65.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Raily Aesthetic Medicine International Holdings's Enterprise Value is HK$93.4 Mil. Raily Aesthetic Medicine International Holdings's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-21.3 Mil. Therefore, Raily Aesthetic Medicine International Holdings's EV-to-EBITDA ratio for today is -4.39.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Raily Aesthetic Medicine International Holdings's Enterprise Value is HK$93.4 Mil. Raily Aesthetic Medicine International Holdings's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was HK$207.1 Mil. Therefore, Raily Aesthetic Medicine International Holdings's EV-to-Revenue ratio for today is 0.45.


Raily Aesthetic Medicine International Holdings Enterprise Value Historical Data

The historical data trend for Raily Aesthetic Medicine International Holdings's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raily Aesthetic Medicine International Holdings Enterprise Value Chart

Raily Aesthetic Medicine International Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial - 644.17 554.88 293.63 208.93

Raily Aesthetic Medicine International Holdings Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 554.88 354.42 293.63 290.66 208.93

Competitive Comparison of Raily Aesthetic Medicine International Holdings's Enterprise Value

For the Medical Care Facilities subindustry, Raily Aesthetic Medicine International Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raily Aesthetic Medicine International Holdings's Enterprise Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raily Aesthetic Medicine International Holdings's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Raily Aesthetic Medicine International Holdings's Enterprise Value falls into.



Raily Aesthetic Medicine International Holdings Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Raily Aesthetic Medicine International Holdings's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as

Raily Aesthetic Medicine International Holdings's Enterprise Value for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raily Aesthetic Medicine International Holdings  (HKSE:02135) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Raily Aesthetic Medicine International Holdings's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=93.399/-35.232
=-2.65

Raily Aesthetic Medicine International Holdings's current Enterprise Value is HK$93.4 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Raily Aesthetic Medicine International Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-35.2 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Raily Aesthetic Medicine International Holdings's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=93.399/-21.294
=-4.39

Raily Aesthetic Medicine International Holdings's current Enterprise Value is HK$93.4 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Raily Aesthetic Medicine International Holdings's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-21.3 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Raily Aesthetic Medicine International Holdings's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=93.399/207.144
=0.45

Raily Aesthetic Medicine International Holdings's current Enterprise Value is HK$93.4 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Raily Aesthetic Medicine International Holdings's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was HK$207.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raily Aesthetic Medicine International Holdings Enterprise Value Related Terms

Thank you for viewing the detailed overview of Raily Aesthetic Medicine International Holdings's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Raily Aesthetic Medicine International Holdings (HKSE:02135) Business Description

Traded in Other Exchanges
N/A
Address
No. 290 North Zhongshan Road, 3-5th Floor, Minhang Tower, Gongshu District, Hangzhou, CHN
Raily Aesthetic Medicine International Holdings Ltd is an aesthetic medical service provider in Zhejiang Province, the PRC. It offers a broad range of aesthetic medical services to clients to meet their different aesthetic and anti-aging objectives. The group is organized into business units based on their services and has three reportable operating segments namely Aesthetic medical services which comprise principally inpatient services including surgical services and outpatient services including injection service, dermatology services, and others; and Consulting service segment which comprise principally management consulting services. Aesthetic medical equipment products comprise principally sales of surgical implants and aesthetic medical skincare products.
Executives
Fu Haishu 2201 Interest of corporation controlled by you
Jin Chunmiao 2202 Interest of your spouse
Ruide Consultation Limited 2101 Beneficial owner
Youxin Management Co., Limited 2101 Beneficial owner
Beauty Milkway (hk) Limited
China Orient Asset Management (international) Holding Limited
China Orient Asset Management Co., Ltd.
Dong Yin Development (holdings) Limited
Wise Leader Assets Ltd.
Shang Hai Dong Hua Jian Kang Guan Li He Huo Qi Ye You Xian He Huo
Dong Fang Zi Chan Guan Li Zhong Guo Kong Gu You Xian Gong Si
Shen Zhen Dong Fang Chuang Ye Tou Zi You Xian Gong Si
Shen Zhen Qian Hai Cai Fu Dong Fang Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si
Qing Hai Sheng Dong Fang Cang Yi Yao Chan Ye Fa Zhan Ji Jin You Xian He Huo
Qing Hai Sheng Dong Fang Cang Yi Yao Chan Ye Tou Zi Guan Li You Xian Gong Si

Raily Aesthetic Medicine International Holdings (HKSE:02135) Headlines

No Headlines